Moderna· @moderna_tx · X·· 2026-08-04AI 评分28
AI 导读
今日我们宣布，在加拿大卫生部批准该研究后，加拿大一项I期临床研究已完成首批受试者接种，该研究评估的是mRNA-1469——我们正在研发的用于预防Bundibugyo埃博拉病毒病的mRNA疫苗。 阅读更多：https://feeds.issuerdirect.com/news-release.html?newsid=5531328107885644&symbol=MRNA
正文
Today we announced that following Health Canada’s authorization of the study, the first participants have been vaccinated in a Phase 1 clinical study in Canada evaluating mRNA-1469, our investigational mRNA vaccine being evaluated to prevent Bundibugyo ebolavirus disease.
Read more: https://feeds.issuerdirect.com/news-release.html?newsid=5531328107885644&symbol=MRNA
来源：Moderna · x.com